GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (LTS:0A57) » Definitions » Cyclically Adjusted Revenue per Share

T2 Biosystems (LTS:0A57) Cyclically Adjusted Revenue per Share : $73.07 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is T2 Biosystems Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

T2 Biosystems's adjusted revenue per share for the three months ended in Jun. 2024 was $0.138. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $73.07 for the trailing ten years ended in Jun. 2024.

During the past 12 months, T2 Biosystems's average Cyclically Adjusted Revenue Growth Rate was -2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-09-22), T2 Biosystems's current stock price is $2.2292. T2 Biosystems's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was $73.07. T2 Biosystems's Cyclically Adjusted PS Ratio of today is 0.03.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of T2 Biosystems was 3.41. The lowest was 0.03. And the median was 0.11.


T2 Biosystems Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for T2 Biosystems's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Cyclically Adjusted Revenue per Share Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.93 348.99

T2 Biosystems Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.50 99.49 348.99 724.15 73.07

Competitive Comparison of T2 Biosystems's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, T2 Biosystems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Cyclically Adjusted PS Ratio falls into.



T2 Biosystems Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, T2 Biosystems's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.138/132.5538*132.5538
=0.138

Current CPI (Jun. 2024) = 132.5538.

T2 Biosystems Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 0.000 100.428 0.000
201412 0.595 99.070 0.796
201503 0.935 99.621 1.244
201506 2.778 100.684 3.657
201509 5.167 100.392 6.822
201512 4.746 99.792 6.304
201603 4.529 100.470 5.975
201606 4.074 101.688 5.311
201609 4.336 101.861 5.643
201612 2.980 101.863 3.878
201703 3.085 102.862 3.975
201706 3.114 103.349 3.994
201709 3.529 104.136 4.492
201712 4.627 104.011 5.897
201803 6.419 105.290 8.081
201806 10.264 106.317 12.797
201809 5.630 106.507 7.007
201812 4.063 105.998 5.081
201903 4.029 107.251 4.980
201906 4.063 108.070 4.984
201909 3.694 108.329 4.520
201912 6.407 108.420 7.833
202003 3.710 108.902 4.516
202006 2.121 108.767 2.585
202009 3.549 109.815 4.284
202012 5.259 109.897 6.343
202103 4.694 111.754 5.568
202106 4.321 114.631 4.997
202109 4.477 115.734 5.128
202112 4.195 117.630 4.727
202203 212.765 121.301 232.503
202206 168.886 125.017 179.068
202209 61.283 125.227 64.869
202212 74.095 125.222 78.433
202303 15.279 127.348 15.904
202306 2.428 128.729 2.500
202309 0.329 129.860 0.336
202312 0.414 129.419 0.424
202403 0.405 131.776 0.407
202406 0.138 132.554 0.138

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


T2 Biosystems  (LTS:0A57) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

T2 Biosystems's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.2292/73.07
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of T2 Biosystems was 3.41. The lowest was 0.03. And the median was 0.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


T2 Biosystems Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

T2 Biosystems Headlines

No Headlines